Fortress Biotech (FBIO) on Friday filed a registration statement for the offering of up to about 6.2 million shares of its common stock by certain selling shareholders.
The prospectus covers the sale from time to time of shares of outstanding common shares and shares issuable upon warrant exercises.
The company will not receive any proceeds from the secondary offering.
Price: 1.4799, Change: -0.01, Percent Change: -0.68
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.